FOR IMMEDIATE RELEASE: NOVEMBER 15, 2017 Contact: Colin Riley (617) 353-5386, email@example.com (Boston) – On Wednesday, November 15, between 9 a.m.- noon, Boston University (BU) will conduct an emergency response exercise at the National Emerging Infectious Diseases Laboratories (NEIDL) located at 620 Albany Street. This simulation is part of the NEIDL’s ongoing... More
Original article from: STAT posted on October 20, 2017. by Hyacinth Empinado Research on dangerous pathogens like Ebola takes place inside highly secure biosafety level-4 (BSL-4) labs. Elke Mühlberger, a researcher at the National Emerging Diseases Laboratory at Boston University, takes you as close to Ebola as you’ll ever get and... More
The BU Annual Fund Leadership Giving Society presents a conversation with Dr. Ronald Corley, professor and chair of the microbiology at the BU School of Medicine and director of the National Emerging Infectious Diseases Laboratories (NEIDL).
Original article from Boston 25 News. May 30, 2017 BOSTON - A lab to study deadly diseases like Ebola and bubonic plague is just one vote away from approval in the heart of Boston. Supporters say it will speed the development of new vaccines and cures. But after 15 year of... More
Original article from WCAI by Heather Goldstone May 22, 2017 Ebola is back. The virus killed more than 11,000 people between 2014 and 2016. It was the largest Ebola outbreak ever documented. Now, health officials say there’s a new outbreak in the Democratic Republic of Congo. Officials are reporting four deaths and... More
Original article in Time Health Magazine - Alexandra Sifferlin May 03, 2017 The Ebola outbreak of 2014 infected more than 28,000 people in West Africa and killed more than 11,000. It also exposed gaps in the world's ability to respond to epidemics of infectious diseases. Are we more prepared now to respond... More
Dr Dennis Carroll is Director of the Emerging Threats Program at the U.S. Agency for International Development. We spoke to him at EIDA2Z about the current approach to tackling emerging diseases – and how we need to change it.
Original article from: Scientific American posted on April 12, 2017. by Helen Branswell When the largest Ebola outbreak in history exploded across West Africa in 2014, public health authorities raced to test experimental vaccines and drugs they hoped would quell the massive epidemic. But the trials process was too slow, and in... More
Original article from: BU Today posted on March 7, 2017. by Art Jahnke Infectious disease experts and administrators from Boston University told the Boston Biosafety Committee (BBC) on Monday night that the ability to conduct research at Biosafety Level 4 (BSL-4) at BU’s National Emerging Infectious Diseases Laboratory (NEIDL) would speed... More
Original article from: BU Today posted on March 6, 2017. by Sara Rimer The Boston Public Health Commission will hold a public meeting this evening, Monday, March 6, to discuss a request by Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) for permission to conduct research at Biosafety Level 4 (BSL-4). More